{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:35:24Z","timestamp":1788975324469,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.xphs.2024.10.017","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T13:07:19Z","timestamp":1729256839000},"page":"402-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Impact of drug incorporation into micelle on reduced griseofulvin and meloxicam permeation across a hollow fiber membrane"],"prefix":"10.1016","volume":"114","author":[{"given":"Roshni P.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4568-6021","authenticated-orcid":false,"given":"Lynne S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5274-4314","authenticated-orcid":false,"given":"James E.","family":"Polli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.xphs.2024.10.017_bib0001","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1021\/acs.molpharmaceut.7b00740","article-title":"Absorptive dissolution testing of supersaturating systems: impact of absorptive sink conditions on solution phase behavior and mass transport","volume":"14","author":"Hate","year":"2017","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.017_bib0002","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1021\/acs.molpharmaceut.8b01117","article-title":"Insight into amorphous solid dispersion performance by coupled dissolution and membrane mass transfer measurements","volume":"16","author":"Hate","year":"2019","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.017_bib0003","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.xphs.2022.09.030","article-title":"Dissolution-hollow fiber membrane (D-HFM) system to anticipate biopharmaceutics risk of tablets and capsules","volume":"112","author":"Adhikari","year":"2023","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2024.10.017_bib0004","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.xphs.2022.07.002","article-title":"Characterization of dissolution-permeation system using hollow fiber membrane module and utility to predict in vivo drug permeation across BCS classes","volume":"111","author":"Adhikari","year":"2022","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.017_bib0005","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ejpb.2011.04.010","article-title":"Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across Caco-2 cell monolayers","volume":"79","author":"Fischer","year":"2011","journal-title":"Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV"},{"issue":"4\u20135","key":"10.1016\/j.xphs.2024.10.017_bib0006","first-page":"237","article-title":"Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers","volume":"16","author":"Rege","year":"2002","journal-title":"Eur J Pharm Sci Off J Eur Fed Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.017_bib0007","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/jps.21919","article-title":"Mechanisms of membrane transport of poorly soluble drugs: role of micelles in oral absorption processes","volume":"99","author":"Yano","year":"2010","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.017_bib0008","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1023\/A:1016033702220","article-title":"The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system","volume":"13","author":"Nerurkar","year":"1996","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.017_bib0009","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1023\/A:1015827624296","article-title":"Intestinal absorption of drugs. III. The influence of taurocholate on the disappearance kinetics of hydrophilic and lipophilic drugs from the small intestine of the rat","volume":"7","author":"Poelma","year":"1990","journal-title":"Pharm Res"},{"issue":"8","key":"10.1016\/j.xphs.2024.10.017_bib0010","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.2042-7158.2011.01301.x","article-title":"In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: the influence of nonionic surfactants","volume":"63","author":"Fischer","year":"2011","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"10.1016\/j.xphs.2024.10.017_bib0011","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1021\/mp200181v","article-title":"The solubility-permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation","volume":"8","author":"Miller","year":"2011","journal-title":"Mol Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.017_bib0012","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/jps.2600531208","article-title":"Effect of complex formation on drug absorption: complexes of salicyclic acid with absorbable and Nonansorbable compounds","volume":"53","author":"Levy","year":"1964","journal-title":"J Pharm Sci"},{"issue":"Suppl 3","key":"10.1016\/j.xphs.2024.10.017_bib0013","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-0773.1971.tb03285.x","article-title":"Effect of complex formation on drug absorption","volume":"29","author":"Levy","year":"1971","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"10.1016\/j.xphs.2024.10.017_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120494","article-title":"In vitro-in vivo correlation in the effect of cyclodextrin on oral absorption of poorly soluble drugs","volume":"600","author":"Aihara","year":"2021","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.017_bib0015","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1021\/acs.molpharmaceut.9b00889","article-title":"Practical approach to modeling the impact of amorphous drug nanoparticles on the oral absorption of poorly soluble drugs","volume":"17","author":"Stewart","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.10.017_bib0016","unstructured":"Food and Drug Administration. Mobic\u00ae(meloxicam) prescribing information https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2004\/20938s004lbl.pdf."},{"key":"10.1016\/j.xphs.2024.10.017_bib0017","unstructured":"Food and Drug Administration. GRIS-PEG\u00ae (griseofulvin ultramicronized) Tables prescribing information https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/050475s057lbl.pdf."},{"issue":"11","key":"10.1016\/j.xphs.2024.10.017_bib0018","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jps.2600701114","article-title":"Solubility behavior of barbituric acids in aqueous solution of sodium alkyl sulfonate as a function of concentration and temperature","volume":"70","author":"Vaution","year":"1981","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.017_bib0019","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1023\/A:1018939006780","article-title":"Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability","volume":"16","author":"Yu","year":"1999","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.017_bib0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jps.2600710120","article-title":"Theoretical and experimental studies of transport of micelle-solubilized solutes","volume":"71","author":"Amidon","year":"1982","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2024.10.017_bib0021","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/jps.20687","article-title":"Permeability assessment of poorly water-soluble compounds under solubilizing conditions: the reciprocal permeability approach","volume":"95","author":"Katneni","year":"2006","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.017_bib0022","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/jps.2600760403","article-title":"Transport of micelle-solubilized steroids across microporous membranes","volume":"76","author":"Johnson","year":"1987","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.017_bib0023","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1172\/JCI108465","article-title":"The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the intestinal mucosal cell","volume":"58","author":"Westergaard","year":"1976","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2024.10.017_bib0024","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpharm.2009.12.014","article-title":"Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect","volume":"387","author":"Sugano","year":"2010","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.017_bib0025","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1021\/acs.molpharmaceut.7b00294","article-title":"In vivo mechanisms of intestinal drug absorption from aprepitant nanoformulations","volume":"14","author":"Roos","year":"2017","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.017_bib0026","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jps.2600760909","article-title":"Dissolution kinetics of griseofulvin in sodium dodecylsulphate solutions","volume":"76","author":"de Smidt","year":"1987","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.017_bib0027","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1208\/s12248-010-9176-2","article-title":"Comparison of drug permeabilities and BCS classification: three lipid-component PAMPA system method versus Caco-2 monolayers","volume":"12","author":"Teksin","year":"2010","journal-title":"AAPS J"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.017_bib0028","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0378-5173(00)00334-3","article-title":"Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification system","volume":"200","author":"Lentz","year":"2000","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.017_bib0029","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/jpet.106.107433","article-title":"Bias in estimation of transporter kinetic parameters from overexpression systems: interplay of transporter expression level and substrate affinity","volume":"320","author":"Balakrishnan","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.xphs.2024.10.017_bib0030","unstructured":"National institute of health. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Griseofulvin."},{"issue":"8","key":"10.1016\/j.xphs.2024.10.017_bib0031","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/jps.20118","article-title":"Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity","volume":"93","author":"Balakrishnan","year":"2004","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.017_bib0032","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0939-6411(02)00089-9","article-title":"Effect of bovine serum albumin on drug permeability estimation across Caco-2 monolayers","volume":"54","author":"Saha","year":"2002","journal-title":"Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV"},{"issue":"11","key":"10.1016\/j.xphs.2024.10.017_bib0033","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1021\/acs.molpharmaceut.0c00599","article-title":"Toward developing discriminating dissolution methods for formulations containing nanoparticulates in solution: the impact of particle drift and drug activity in solution","volume":"17","author":"Arce","year":"2020","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.017_bib0034","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1021\/acs.molpharmaceut.2c00124","article-title":"Mechanisms and extent of enhanced passive permeation by colloidal drug particles","volume":"19","author":"Narula","year":"2022","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.017_bib0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0301-4622(92)80045-7","article-title":"Kinetic model for membrane transport. III. Solute transport through an asymmetrical membrane","volume":"43","author":"Makino","year":"1992","journal-title":"Biophys Chem"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.017_bib0036","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/cjce.5450800207","article-title":"Extraction of a dissolved organic contaminant from water into an aqueous surfactant solution across a microporous membrane","volume":"80","author":"Marx","year":"2002","journal-title":"Can J Chem Eng"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2024.10.017_bib0037","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.memsci.2010.08.052","article-title":"Micellar-enhanced ultrafiltration of methylene blue from dye wastewater via a polysulfone hollow fiber membrane","volume":"365","author":"Huang","year":"2010","journal-title":"J Membr Sci"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.017_bib0038","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-199936030-00004","article-title":"Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications","volume":"36","author":"Fleisher","year":"1999","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.017_bib0039","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: transport\/absorption\/elimination interplay and development of a biopharmaceutics drug disposition classification system","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm Res"},{"issue":"6","key":"10.1016\/j.xphs.2024.10.017_bib0040","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s11095-007-9236-1","article-title":"Predicting effect of food on extent of drug absorption based on physicochemical properties","volume":"24","author":"Gu","year":"2007","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.017_bib0041","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF03188836","article-title":"Inter- and intra-subject variability of metoprolol kinetics after intravenous administration","volume":"19","author":"Richard","year":"1994","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"S2","key":"10.1016\/j.xphs.2024.10.017_bib0042","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2125.1985.tb02770.x","article-title":"Influence of food on the absorption of metoprolol administered as an Oros drug delivery system to man","volume":"19","author":"Lecaillon","year":"1985","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.017_bib0043","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11095-020-02948-z","article-title":"Negative food effect of danirixin: use of PBPK modelling to explore the effect of formulation and meal type on clinical PK","volume":"37","author":"Lloyd","year":"2020","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.017_bib0044","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.xphs.2019.11.017","article-title":"Prediction of pH-dependent drug-drug interactions for basic drugs using physiologically based biopharmaceutics modeling: industry case studies","volume":"109","author":"Mitra","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.10.017_bib0045","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejpb.2016.09.014","article-title":"Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers","volume":"109","author":"Rubbens","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.017_bib0046","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/cpdd.602","article-title":"Relative bioavailability and food effect evaluation for 2 tablet formulations of asciminib in a 2-arm, crossover, randomized, open-label study in healthy volunteers","volume":"8","author":"Menssen","year":"2019","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.xphs.2024.10.017_bib0047","unstructured":"CENTER FOR DRUG EVALUATION AND RESEARCH. Food and drug administration product quality review NDA 215358 for asciminib\/film-coated tablets https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2021\/215358Orig1s000,Orig2s000ChemR.pdf. Published online September 27, 2021."},{"issue":"7","key":"10.1016\/j.xphs.2024.10.017_bib0048","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1021\/acs.molpharmaceut.0c00043","article-title":"Biopharmaceutic In Vitro In Vivo extrapolation (IVIV_E) informed physiologically-based pharmacokinetic model of ritonavir norvir tablet absorption in humans under fasted and fed state conditions","volume":"17","author":"Arora","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.10.017_bib0049","unstructured":"Center for Drug Evaluation and Research. Food and drug administration chemistry review for ritonavir application number: 22\u2013417 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2010\/022417s000_ChemR.pdf. Published online December 18, 2009."}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924004520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924004520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T01:36:06Z","timestamp":1734744966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924004520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0022354924004520"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.10.017","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of drug incorporation into micelle on reduced griseofulvin and meloxicam permeation across a hollow fiber membrane","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}